<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>IUIS classification of immunodeficiencies affecting cellular and humoral immunity (category I inborn errors of immunity)</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">IUIS classification of immunodeficiencies affecting cellular and humoral immunity (category I inborn errors of immunity)</h1>
<div class="graphic"><div class="figure"><div class="ttl">IUIS classification of immunodeficiencies affecting cellular and humoral immunity (category I inborn errors of immunity)</div><div class="cntnt"><table cellspacing="0"><colgroup span="8" width="12.5%"></colgroup> <tbody> <tr> <td class="subtitle1">Disease</td> <td class="subtitle1">Genetic defect</td> <td class="subtitle1">Inheritance</td> <td class="subtitle1">OMIM</td> <td class="subtitle1">T cells</td> <td class="subtitle1">B cells</td> <td class="subtitle1">Immunoglobulin</td> <td class="subtitle1">Associated features</td> </tr> <tr> <td class="subtitle2_left" colspan="8">T-B+ SCID</td> </tr> <tr> <td class="indent1">Gamma-c deficiency (common gamma chain SCID, CD132 deficiency)</td> <td>IL-2 receptor subunit gamma (<em>IL2RG</em>)</td> <td>XL</td> <td><a href="https://www.omim.org/entry/308380?search=308380&amp;highlight=308380" target="_blank">308380</a></td> <td>Very low</td> <td>Normal to high</td> <td>Low</td> <td>Low NK</td> </tr> <tr> <td class="indent1">JAK3 deficiency</td> <td>Janus kinase 3 (<em>JAK3</em>)</td> <td>AR</td> <td><a href="https://www.omim.org/entry/600173?search=600173&amp;highlight=600173" target="_blank">600173</a></td> <td>Very low</td> <td>Normal to high</td> <td>Low</td> <td>Low NK</td> </tr> <tr> <td class="indent1">IL7R-alpha deficiency</td> <td>IL-7 receptor (<em>IL7R</em>)</td> <td>AR</td> <td><a href="https://www.omim.org/entry/146661" target="_blank">146661</a></td> <td>Very low</td> <td>Normal to high</td> <td>Low</td> <td>Normal NK</td> </tr> <tr> <td class="indent1">CD45 deficiency</td> <td>Protein tyrosine phosphatase receptor type C (<em>PTPRC</em>)</td> <td>AR</td> <td><a href="https://www.omim.org/entry/151460" target="_blank">151460</a></td> <td>Very low</td> <td>Normal</td> <td>Low</td> <td>Normal gamma/delta T cells</td> </tr> <tr> <td class="indent1">CD3 delta deficiency</td> <td>CD3 delta subunit of TCR complex (<em>CD3D</em>)</td> <td>AR</td> <td><a href="https://www.omim.org/entry/186790" target="_blank">186790</a></td> <td>Very low</td> <td>Normal</td> <td>Low</td> <td>Normal NK, no gamma/delta T cells</td> </tr> <tr> <td class="indent1">CD3 epsilon deficiency</td> <td>CD3 epsilon subunit of TCR complex (<em>CD3E</em>)</td> <td>AR</td> <td><a href="https://www.omim.org/entry/186830" target="_blank">186830</a></td> <td>Very low</td> <td>Normal</td> <td>Low</td> <td>Normal NK, no gamma/delta T cells</td> </tr> <tr> <td class="indent1">CD3 zeta deficiency</td> <td>CD3 zeta subunit of TCR complex (<em>CD3Z</em>)</td> <td>AR</td> <td><a href="https://www.omim.org/entry/186780" target="_blank">186780</a></td> <td>Very low</td> <td>Normal</td> <td>Low</td> <td>Normal NK, no gamma/delta T cells</td> </tr> <tr> <td class="indent1">Coronin-1A deficiency</td> <td>Coronin 1A (<em>CORO1A</em>)</td> <td>AR</td> <td><a href="https://www.omim.org/entry/605000" target="_blank">605000</a></td> <td>Very low</td> <td>Normal</td> <td>Low</td> <td>Detectable thymus</td> </tr> <tr> <td class="indent1">LAT deficiency</td> <td>Linker for activation of T cells (<em>LAT</em>)</td> <td>AR</td> <td><a href="https://www.omim.org/entry/602354" target="_blank">602354</a></td> <td>Normal to low</td> <td>Normal to low</td> <td>High</td> <td>Typical SCID or CID, the latter with adenopathy, splenomegaly, recurrent infections, autoimmunity</td> </tr> <tr> <td class="indent1">SLP76 deficiency</td> <td>Lymphocyte cytosolic protein 2 (<em>LCP2</em>)</td> <td>AR</td> <td><a href="https://www.omim.org/entry/619374" target="_blank">619374</a></td> <td>Reduced</td> <td>Normal</td> <td>High IgM; low IgA</td> <td>Early-onset skin abscesses, rash, recurrent infections, autoimmunity</td> </tr> <tr> <td class="subtitle2_left" colspan="8">T-B- SCID</td> </tr> <tr> <td class="indent1" rowspan="2">RAG deficiency</td> <td>Recombination activating 1 (<em>RAG1</em>)</td> <td>AR</td> <td><a href="https://www.omim.org/entry/179615" target="_blank">179615</a></td> <td>Very low</td> <td>Very low</td> <td>Decreased</td> <td>Normal NK cell number but increased risk of graft rejection, possibly due to activated NK cells</td> </tr> <tr> <td>Recombination activating 2 (<em>RAG2</em>)</td> <td>AR</td> <td><a href="https://www.omim.org/entry/179616" target="_blank">179616</a></td> <td>Very low</td> <td>Very low</td> <td>Decreased</td> <td>Normal NK cell number but increased risk of graft rejection, possibly due to activated NK cells</td> </tr> <tr> <td class="indent1">DCLRE1C (Artemis) deficiency</td> <td>DNA cross-link repair 1C (<em>DCLRE1C</em>)</td> <td>AR</td> <td><a href="https://www.omim.org/entry/605988" target="_blank">605988</a></td> <td>Very low</td> <td>Very low</td> <td>Decreased</td> <td>Normal NK cell number but increased risk of graft rejection, possibly due to activated NK cells, radiation sensitivity</td> </tr> <tr> <td class="indent1">DNA PKcs deficiency</td> <td>Protein kinase, DNA-activated, catalytic subunit (<em>PRKDC</em>)</td> <td>AR</td> <td><a href="https://www.omim.org/entry/615966" target="_blank">615966</a></td> <td>Very low</td> <td>Very low</td> <td>Variable</td> <td>Normal NK, radiation sensitivity, microcephaly</td> </tr> <tr> <td class="indent1">Cernunnos/XLF deficiency</td> <td>Nonhomologous end joining factor 1 (<em>NHEJ1</em>)</td> <td>AR</td> <td><a href="https://www.omim.org/entry/611290" target="_blank">611290</a></td> <td>Very low</td> <td>Very low</td> <td>Decreased</td> <td>Normal NK, radiation sensitivity, microcephaly</td> </tr> <tr> <td class="indent1">DNA ligase IV deficiency</td> <td>DNA ligase 4 (<em>LIG4</em>)</td> <td>AR</td> <td><a href="https://www.omim.org/entry/601837" target="_blank">601837</a></td> <td>Very low</td> <td>Very low</td> <td>Decreased</td> <td>Normal NK, radiation sensitivity, microcephaly</td> </tr> <tr> <td class="indent1">Adenosine deaminase deficiency</td> <td>Adenosine deaminase (<em>ADA</em>)</td> <td>AR</td> <td><a href="https://www.omim.org/entry/608958" target="_blank">608958</a></td> <td>Very low</td> <td>Low, decreasing</td> <td>Low, decreasing</td> <td>Low NK, bone defects, may have pulmonary alveolar proteinosis, cognitive defects</td> </tr> <tr> <td class="indent1">AK2 defect</td> <td>Adenylate kinase 2 (<em>AK2</em>)</td> <td>AR</td> <td><a href="https://www.omim.org/entry/103020" target="_blank">103020</a></td> <td>Very low</td> <td>Very low</td> <td>Decreased</td> <td>Reticular dysgenesis with neutropenia, deafness</td> </tr> <tr> <td class="indent1">Activated RAC2 defect</td> <td>Rac family small GTPase 2 (<em>RAC2</em>)</td> <td>AD GOF</td> <td><a href="https://www.omim.org/entry/602049" target="_blank">602049</a></td> <td>Very low</td> <td>Very low</td> <td>Low; poor specific antibody responses</td> <td>Recurrent bacterial and viral infections, lymphoproliferation, neutropenia</td> </tr> <tr> <td class="subtitle2_left" colspan="8">CID, generally less profound than SCID</td> </tr> <tr> <td class="indent1">CD40 ligand (<em>CD154</em>) deficiency</td> <td>CD40 ligand (CD40LG)</td> <td>XL</td> <td><a href="https://www.omim.org/entry/308230" target="_blank">308230</a></td> <td>Normal to low</td> <td>sIgM<sup>+</sup>IgD<sup>+</sup> naïve B cells present; IgG<sup>+</sup>, IgA<sup>+</sup>, IgE<sup>+</sup> memory B cells absent</td> <td>IgM normal or high; other immunoglobulin isotypes low</td> <td>Severe and opportunistic infections, idiopathic neutropenia, hepatitis and cholangitis, <em>Cryptosporidium</em> infections, cholangiocarcinoma, autoimmune blood cytopenias, peripheral neuroectodermal tumors</td> </tr> <tr> <td class="indent1">CD40 deficiency</td> <td>CD40 molecule (<em>CD40</em>)</td> <td>AR</td> <td><a href="https://www.omim.org/entry/606843" target="_blank">606843</a></td> <td>Normal</td> <td>sIgM<sup>+</sup>IgD<sup>+</sup> naïve B cells present; IgG<sup>+</sup>, IgA<sup>+</sup>, IgE<sup>+</sup> memory B cells absent</td> <td>IgM normal or high; other immunoglobulin isotypes low</td> <td>Neutropenia, opportunistic infections, gastrointestinal and biliary tract and liver disease, <em>Cryptosporidium</em> infections</td> </tr> <tr> <td class="indent1">ICOS deficiency</td> <td>Inducible T cell costimulator (<em>ICOS</em>)</td> <td>AR</td> <td><a href="https://www.omim.org/entry/604558" target="_blank">604558</a></td> <td>Normal</td> <td>Normal</td> <td>Low</td> <td>Recurrent infections, autoimmunity, gastroenteritis, granulomas</td> </tr> <tr> <td class="indent1">ICOSL deficiency</td> <td>Inducible T cell costimulator ligand (<em>ICOSLG</em>)</td> <td>AR</td> <td><a href="https://www.omim.org/entry/605717" target="_blank">605717</a></td> <td>Low</td> <td>Low</td> <td>Low</td> <td>Recurrent bacterial and viral infections, neutropenia</td> </tr> <tr> <td class="indent1">CD3 gamma deficiency</td> <td>CD3 gamma subunit of TCR complex (<em>CD3G</em>)</td> <td>AR</td> <td><a href="https://www.omim.org/entry/186740" target="_blank">186740</a></td> <td>Normal number but low TCR expression</td> <td>Normal</td> <td>Normal</td> <td>Immunodeficiency and autoimmunity of variable severity</td> </tr> <tr> <td class="indent1">CD8 deficiency</td> <td>CD8a molecule (<em>CD8A</em>)</td> <td>AR</td> <td><a href="https://www.omim.org/entry/186910" target="_blank">186910</a></td> <td>Absent CD8; normal CD4</td> <td>Normal</td> <td>Normal</td> <td>Recurrent infections, may be asymptomatic</td> </tr> <tr> <td class="indent1">ZAP-70 deficiency (ZAP70 LOF)</td> <td>Zeta chain of T cell receptor associated protein kinase 70 (<em>ZAP70</em>)</td> <td>AR</td> <td><a href="https://www.omim.org/entry/269840" target="_blank">269840</a></td> <td>Low CD8 number; normal CD4 number but with poor function</td> <td>Normal</td> <td>Normal</td> <td>May have immune dysregulation, autoimmunity</td> </tr> <tr> <td class="indent1">ZAP-70 combined hypomorphic and activating mutations</td> <td>Zeta chain of T cell receptor associated protein kinase 70 (<em>ZAP70</em>)</td> <td>AR (LOF/GOF)</td> <td><a href="https://www.omim.org/entry/617006" target="_blank">617006</a></td> <td>Decreased CD8; normal or decreased CD4 cells</td> <td>Normal or decreased</td> <td>Normal IgA, low IgM, low/normal IgG; protective AB responses to vaccines</td> <td>Severe autoimmunity, bullous pemphigoid, inflammatory colitis</td> </tr> <tr> <td class="indent1" rowspan="4">MHC class I deficiency</td> <td>Transporter 1, ATP binding cassette subfamily B member (<em>TAP1</em>)</td> <td>AR</td> <td><a href="https://www.omim.org/entry/170260" target="_blank">170260</a></td> <td>Low CD8; normal CD4; absent MHC I on lymphocytes</td> <td>Normal</td> <td>Normal</td> <td>Vasculitis, pyoderma gangrenosum</td> </tr> <tr> <td>Transporter 2, ATP binding cassette subfamily B member (<em>TAP2</em>)</td> <td>AR</td> <td><a href="https://www.omim.org/entry/170261" target="_blank">170261</a></td> <td>Low CD8; normal CD4; absent MHC I on lymphocytes</td> <td>Normal</td> <td>Normal</td> <td>Vasculitis, pyoderma gangrenosum</td> </tr> <tr> <td>TAP binding protein (<em>TAPBP</em>)</td> <td>AR</td> <td><a href="https://www.omim.org/entry/601962" target="_blank">601962</a></td> <td>Low CD8; normal CD4; absent MHC I on lymphocytes</td> <td>Normal</td> <td>Normal</td> <td>Vasculitis, pyoderma gangrenosum</td> </tr> <tr> <td>Beta-2-microglobulin (<em>B2M</em>)</td> <td>AR</td> <td><a href="https://www.omim.org/entry/109700" target="_blank">109700</a></td> <td>Low CD8; normal CD4; absent MHC I on lymphocytes</td> <td>Normal</td> <td>Normal</td> <td>Sinopulmonary infections, cutaneous granulomas, absent B2M-associated proteins MHC-I, CD1a, CD1b, CD1c</td> </tr> <tr> <td class="indent1" rowspan="4">MHC class II deficiency group A, B, C, D</td> <td>Class II MHC transactivator (<em>CIITA</em>)</td> <td>AR</td> <td><a href="https://www.omim.org/entry/600005" target="_blank">600005</a></td> <td>Low CD4+ T cells; reduced MHC II expression on lymphocytes</td> <td>Normal</td> <td>Normal to low</td> <td>Failure to thrive, respiratory and gastrointestinal infections, liver/biliary tract disease</td> </tr> <tr> <td>Regulatory factor X-associated ankyrin-containing protein (<em>RFXANK</em>)</td> <td>AR</td> <td><a href="https://www.omim.org/entry/603200" target="_blank">603200</a></td> <td>Low CD4+ T cells; reduced MHC II expression on lymphocytes</td> <td>Normal</td> <td>Normal to low</td> <td>Failure to thrive, respiratory and gastrointestinal infections, liver/biliary tract disease</td> </tr> <tr> <td>Regulatory factor X5 (<em>RFX5</em>)</td> <td>AR</td> <td><a href="https://www.omim.org/entry/601863" target="_blank">601863</a></td> <td>Low CD4+ T cells; reduced MHC II expression on lymphocytes</td> <td>Normal</td> <td>Normal to low</td> <td>Failure to thrive, respiratory and gastrointestinal infections, liver/biliary tract disease</td> </tr> <tr> <td>Regulatory factor X associated protein (<em>RFXAP</em>)</td> <td>AR</td> <td><a href="https://www.omim.org/entry/601861" target="_blank">601861</a></td> <td>Low CD4+ T cells; reduced MHC II expression on lymphocytes</td> <td>Normal</td> <td>Normal to low</td> <td>Failure to thrive, respiratory and gastrointestinal infections, liver/biliary tract disease</td> </tr> <tr> <td class="indent1">IKAROS deficiency</td> <td>IKAROS family zinc finger 1 (<em>IKZF1</em>)</td> <td>AD DN</td> <td><a href="https://www.omim.org/entry/603023" target="_blank">603023</a></td> <td>No memory T cells</td> <td>No memory B cells</td> <td>Low immunoglobulin</td> <td>Recurrent sinopulmonary infections, pneumocystis, early CID onset</td> </tr> <tr> <td class="indent1">DOCK8 deficiency</td> <td>Dedicator of cytokinesis 8 (<em>DOCK8</em>)</td> <td>AR</td> <td><a href="https://www.omim.org/entry/243700" target="_blank">243700</a></td> <td>T cell lymphopenia; reduced naïve CD8 T cells; increased exhausted CD8+ TEM cells; reduced MAIT, NKT cells; increased gamma-delta T cells; poor proliferation; few Treg with poor function</td> <td>Increased total B cell; reduced memory B cells; poor peripheral B cell tolerance</td> <td>Low IgM; normal/high IgG and IgA; very high IgE; poor antibody responses</td> <td>Low NK cells with poor function; eosinophilia; recurrent infections; cutaneous viral, fungal, and staphylococcal infections; severe atopy/allergic disease; cancer diathesis</td> </tr> <tr> <td class="indent1">DOCK2 deficiency</td> <td>Dedicator of cytokinesis 2 (<em>DOCK2</em>)</td> <td>AR</td> <td><a href="https://www.omim.org/entry/603122" target="_blank">603122</a></td> <td>Low</td> <td>Normal</td> <td>IgG normal or low; poor antibody responses</td> <td>Early invasive herpes vial bacterial infections, normal NK cell number but defective function, poor interferon responses to hematopoietic and nonhematopoietic cells</td> </tr> <tr> <td class="indent1" rowspan="2">Polymerase delta deficiency</td> <td>DNA polymerase delta 1, catalytic subunit (<em>POLD1</em>)</td> <td>AR</td> <td><a href="https://www.omim.org/entry/174761" target="_blank">174761</a></td> <td>Low CD4 T cells</td> <td>Low B cells but normal maturation</td> <td>Low IgG</td> <td>Recurrent respiratory tract infections, skin infections, warts and molluscum, short stature, intellectual disability</td> </tr> <tr> <td>DNA polymerase delta 2, accessory subunit (<em>POLD2</em>)</td> <td>AR</td> <td><a href="https://www.omim.org/entry/600815" target="_blank">600815</a></td> <td>Low CD4 T cells</td> <td>Low B cells but normal maturation</td> <td>Low IgG</td> <td>Recurrent respiratory tract infections, skin infections, warts and molluscum, short stature, intellectual disability</td> </tr> <tr> <td class="indent1">RHOH deficiency</td> <td>Ras homolog family member H (<em>RHOH</em>)</td> <td>AR</td> <td><a href="https://www.omim.org/entry/602037" target="_blank">602037</a></td> <td>Normal; few naïve T cells; restricted repertoire; poor proliferation to CD3</td> <td>Normal</td> <td>Normal</td> <td>HPV infection, lung granulomas, molluscum contagiosum, lymphoma</td> </tr> <tr> <td class="indent1">STK4 deficiency</td> <td>Serine/threonine kinase 4 (<em>STK4</em>)</td> <td>AR</td> <td><a href="https://www.omim.org/entry/614868" target="_blank">614868</a></td> <td>CD4 lymphopenia; reduced naïve T cells; increased TEM and TEMRA cells; poor proliferation</td> <td>Reduced memory B cells</td> <td>Reduced IgM; increased IgG, IgA, and IgE; impaired antibody responses</td> <td>Intermittent neutropenia; bacterial, viral (HPV, EBV, molluscum), and candidal infections; lymphoproliferation; autoimmune cytopenias; lymphoma; congenital heart disease</td> </tr> <tr> <td class="indent1">TCR-alpha deficiency</td> <td>T cell receptor alpha constant (<em>TRAC</em>)</td> <td>AR</td> <td><a href="https://www.omim.org/entry/615387" target="_blank">615387</a></td> <td>Absent TCR-alpha-beta except for a minor CD3-dim TCR-alpha-beta population; most T cells gamma-delta; poor proliferation</td> <td>Normal</td> <td>Normal</td> <td>Recurrent viral, bacterial, fungal infections; immune dysregulation and autoimmunity; diarrhea</td> </tr> <tr> <td class="indent1">LCK deficiency</td> <td>LCK proto-oncogene, Src family tyrosine kinase (<em>LCK</em>)</td> <td>AR</td> <td><a href="https://www.omim.org/entry/615758" target="_blank">615758</a></td> <td>Low CD4+; low Treg; restricted T cell repertoire; poor TCR signaling</td> <td>Normal</td> <td>Normal IgG and IgA; high IgM</td> <td>Recurrent infections, immune dysregulation, autoimmunity</td> </tr> <tr> <td class="indent1">ITK deficiency</td> <td>IL-2 inducible T cell kinase (<em>ITK</em>)</td> <td>AR</td> <td><a href="https://www.omim.org/entry/186973" target="_blank">186973</a></td> <td>Progressive CD4 T cell lymphopenia; reduced T cell activation</td> <td>Normal</td> <td>Normal to low serum immunoglobulin</td> <td>EBV-associated B cell lymphoproliferation, lymphoma, immune dysregulation</td> </tr> <tr> <td class="indent1">MALT1 deficiency</td> <td>MALT1 paracaspase (<em>MALT1</em>)</td> <td>AR</td> <td><a href="https://www.omim.org/entry/615468" target="_blank">615468</a></td> <td>Normal number; poor proliferation</td> <td>Normal</td> <td>Normal levels; poor specific antibody response</td> <td>Bacterial, fungal and viral infections</td> </tr> <tr> <td class="indent1">CARD11 deficiency</td> <td>Caspase recruitment domain family member 11 (<em>CARD11</em>)</td> <td>AR LOF</td> <td><a href="https://www.omim.org/entry/615206" target="_blank">615206</a></td> <td>Normal number; predominantly naïve T cells; poor proliferation</td> <td>Normal; transitional B cell predominance</td> <td>Absent/low</td> <td><em>Pneumocystis jirovecii</em> pneumonia, bacterial and viral infections</td> </tr> <tr> <td class="indent1">BCL10 deficiency</td> <td>BCL10 immune signaling adaptor (<em>BCL10</em>)</td> <td>AR</td> <td><a href="https://www.omim.org/entry/616098" target="_blank">616098</a></td> <td>Normal number; few memory T and Treg cels; poor antigen and anti-CD3 proliferation</td> <td>Normal number; decreased memory and switched B cells</td> <td>Low</td> <td>Recurrent bacterial and viral infections, candidiasis, gastroenteritis</td> </tr> <tr> <td class="indent1">IL-21 deficiency</td> <td>Interleukin 21 (<em>IL21</em>)</td> <td>AR</td> <td><a href="https://www.omim.org/entry/615767" target="_blank">615767</a></td> <td>Normal number; normal/low function</td> <td>Low; decreased memory and switched B cells</td> <td>Hypogammaglobulinemia; poor specific antibody responses; increased IgE</td> <td>Severe early-onset colitis, recurrent sinopulmonary infections</td> </tr> <tr> <td class="indent1">IL-21R deficiency</td> <td>Interleukin 21 receptor (<em>IL21R</em>)</td> <td>AR</td> <td><a href="https://www.omim.org/entry/615207" target="_blank">615207</a></td> <td>Normal number; low cytokine production; poor antigen proliferation</td> <td>Normal; decreased memory and switched B cells</td> <td>Hypogammaglobulinemia; poor specific antibody responses; increased IgE</td> <td>Recurrent infections, <em>P. jirovecii</em>, <em>Cryptosporidium</em> infections, liver disease</td> </tr> <tr> <td class="indent1">OX40 deficiency</td> <td>TNF receptor superfamily member 4 (<em>TNFRSF4</em>)</td> <td>AR</td> <td><a href="https://www.omim.org/entry/615593" target="_blank">615593</a></td> <td>Normal number; low antigen-specific memory CD4+</td> <td>Normal number; low memory B cells</td> <td>Normal</td> <td>Impaired immunity to HHV8, Kaposi sarcoma</td> </tr> <tr> <td class="indent1">IKBKB deficiency</td> <td>Inhibitor of NF-kB kinase subunit beta (<em>IKBKB</em>)</td> <td>AR</td> <td><a href="https://www.omim.org/entry/615592" target="_blank">615592</a></td> <td>Normal number; absent Treg and gamma-delta T cells; impaired TCR activation</td> <td>Normal number; poor function</td> <td>Low</td> <td>Recurrent bacterial, viral, and fungal infections; opportunistic infections</td> </tr> <tr> <td class="indent1">NIK deficiency</td> <td>Mitogen-activated protein kinase kinase kinase 14 (<em>MAP3K14</em>)</td> <td>AR</td> <td><a href="https://www.omim.org/entry/604655" target="_blank">604655</a></td> <td>Normal number; poor proliferation to antigen</td> <td>Low; low switched memory B cells</td> <td>Low immunoglobulins</td> <td>Low NK number and function; recurrent bacterial, viral, and <em>Cryptosporidium</em> infections</td> </tr> <tr> <td class="indent1">RelB deficiency</td> <td>RELB proto-oncogene, NF-kB subunit (<em>RELB</em>)</td> <td>AR</td> <td><a href="https://www.omim.org/entry/604758" target="_blank">604758</a></td> <td>Normal number; poor diversity; reduced proliferation to mitogens; no response to antigen</td> <td>Marked increased in B cell number</td> <td>Normal immunoglobulin levels but impaired specific antibody responses</td> <td>Recurrent infections</td> </tr> <tr> <td class="indent1">RelA haploinsufficiency</td> <td>RELA proto-oncogene, NF-kB subunit (<em>RELA</em>)</td> <td>AD</td> <td><a href="https://www.omim.org/entry/618287" target="_blank">618287</a></td> <td>Normal/increased</td> <td>Normal</td> <td>Normal</td> <td>Chronic mucocutaneous ulceration, impaired NF-kB activation, reduced production of inflammatory cytokines</td> </tr> <tr> <td class="indent1">Moesin deficiency</td> <td>Moesin (<em>MSN</em>)</td> <td>XL</td> <td><a href="https://www.omim.org/entry/300988" target="_blank">300988</a></td> <td>Normal number; defective migration, proliferation</td> <td>Low number</td> <td>Low immunoglobulins over time</td> <td>Recurrent infections with bacteria, varicella, neutropenia</td> </tr> <tr> <td class="indent1">TFRC deficiency</td> <td>Transferrin receptor (<em>TFRC</em>)</td> <td>AR</td> <td><a href="https://www.omim.org/entry/616740" target="_blank">616740</a></td> <td>Normal number; poor proliferation</td> <td>Normal number; low memory B cells</td> <td>Low</td> <td>Recurrent infections, neutropenia, thrombocytopenia</td> </tr> <tr> <td class="indent1">c-Rel deficiency</td> <td>REL proto-oncogene, NF-kB subunit (<em>REL</em>)</td> <td>AR</td> <td><a href="https://www.omim.org/entry/164910" target="_blank">164910</a></td> <td>Normal; decreased memory CD4; poor proliferation</td> <td>Low, mostly naïve; few switched memory B cells; impaired proliferation</td> <td>Low; poor specific antibody responses</td> <td>Recurrent infections with bacterial, mycobacteria, <em>Salmonella</em>, and opportunistic organisms; defective innate immunity</td> </tr> <tr> <td class="indent1">FCHO1 deficiency</td> <td>FCH and mu domain containing endocytic adaptor 1 (<em>FCHO1</em>)</td> <td>AR</td> <td><a href="https://www.omim.org/entry/613437" target="_blank">613437</a></td> <td>Low; poor proliferation</td> <td>Normal number</td> <td>Normal</td> <td>Recurrent infections (viral, mycobacteria, bacterial, fungal), lymphoproliferation, failure to thrive, increased activation-induced T cell death, defective clathrin-mediated endocytosis</td> </tr> <tr> <td class="indent1">PAX1 deficiency</td> <td>Paired box 1 (<em>PAX1</em>)</td> <td>AR</td> <td><a href="https://www.omim.org/entry/615560" target="_blank">615560</a></td> <td>Severe T cell lymphopenia; low TRECs</td> <td>Normal number</td> <td>Normal</td> <td>Omenn-like syndrome (erythroderma, lymphocytosis, eosinophilia, severe/recurrent infections), no thymus, T cell deficiency not corrected by HCT, otofaciocervical syndrome type 2, ear abnormalities</td> </tr> <tr> <td class="indent1">ITPKB deficiency</td> <td>Inositol-trisphosphate 3-kinase B (<em>ITPKB</em>)</td> <td>AR</td> <td> </td> <td>Very few T cells</td> <td>Normal</td> <td>Normal IgM, IgA; low IgG</td> <td>Failure to thrive, recurrent bacterial/fungal infections, pan-leukopenia, anemia, thrombocytopenia</td> </tr> <tr> <td class="indent1">SASH3 deficiency</td> <td>SAM and SH3 domain containing 3 (<em>SASH3</em>)</td> <td>XL</td> <td> </td> <td>T/NK cell lymphopenia</td> <td>B cell lymphopenia</td> <td>Low; poor specific antibody responses</td> <td>Recurrent sinopulmonary, cutaneous, and mucosal infections; refractor autoimmune cytopenia/neutropenia</td> </tr> <tr> <td class="indent1">MAN2B2 deficiency</td> <td>Mannosidase alpha class 2B member 2 (<em>MAN2B2</em>)</td> <td>AR</td> <td> </td> <td>Low T cells</td> <td>Low B cells</td> <td>Normal/low</td> <td>Recurrent infections, vasculitis, arthritis, failure to thrive, microcephaly, neurodevelopmental delay, congenital disorder of glycosylation</td> </tr> <tr> <td class="indent1">COPG1 deficiency</td> <td>COPI coat complex subunit gamma 1 (<em>COPG1</em>)</td> <td>AR</td> <td> </td> <td>T cell lymphopenia</td> <td>Normal</td> <td>Normal but poor immunoglobulin response to vaccines</td> <td>Recurrent pneumonia, viral respiratory infections, chronic EBV, CMV viremia, failure to thrive, bronchiectasis</td> </tr> <tr> <td class="indent1">HELIOS deficiency</td> <td>IKAROS family zinc finger 2 (<em>IKZF2</em>)</td> <td>AD, AR</td> <td> </td> <td>Increased activated T cells</td> <td>Normal number; reduced memory</td> <td>Reduced</td> <td>Recurrent upper respiratory infections/pneumonia, thrush, mucosal ulcers, chronic lymphadenopathy, SLE, ITP, AIHA (Evans syndrome), EBV-associated HLH, lymphoma</td> </tr> <tr> <td class="indent1">IKK-alpha deficiency</td> <td>Component of inhibitor of nuclear factor kappa B kinase complex (<em>CHUK</em>)</td> <td>AR</td> <td> </td> <td>Normal</td> <td>Reduced</td> <td>Low</td> <td>Recurrent bacterial, viral, and fungal infections; absent secondary lymphoid tissues; skeletal abnormalities, failure to thrive</td> </tr> </tbody></table></div><div class="graphic_lgnd">Total number of mutant genes: 66. SCID/CID spectrum: Infants with SCID who have maternal T cell engraftment may have T cells in normal numbers that do not function normally; these cells may cause autoimmune cytopenias or graft-versus-host disease. Hypomorphic mutations in several of the genes that cause SCID may result in Omenn syndrome, "leaky" SCID, or still less profound CID phenotypes. Both Omenn syndrome and leaky SCID can be associated with &gt;300 autologous T cells/uL of peripheral blood and reduced, rather than absent, proliferative responses when compared with typical SCID caused by null mutations. A spectrum of clinical findings including typical SCID, Omenn syndrome, leaky SCID, CID, granulomas with T lymphopenia, autoimmunity, and CD4 T lymphopenia can be found in an allelic series of <em>RAG1/2</em> and other SCID-associated genes. There can be clinical overlap between some genes listed in this table and those listed for autoinflammatory disorders.</div><div class="graphic_footnotes">IUIS: International Union of Immunological Societies; 
    SCID: severe combined immunodeficiency; 
    CD: cluster of differentiation; 
    IL: interleukin; 
    XL: X linked; 
    NK: natural killer; 
    AR: autosomal recessive; 
    TCR: T cell receptor; 
    CID: combined immunodeficiency; 
    SLP76: SH2 domain-containing leukocyte protein of 76kD; 
    IgM: immunoglobulin M; 
    IgA: immunoglobulin A; 
    DNA: deoxyribonucleic acid; 
    XLF: XRCC4-like factor; 
    AD: autosomal dominant; 
    GOF: gain of function; 
    sIgM: serum immunoglobulin M; 
    IgD: immunoglobulin D; 
    IgG: immunoglobulin G; 
    IgE: immunoglobulin E; 
    LOF: loss of function; 
    MHC: major histocompatability complex; 
    DN: dominant negative; 
    TEM: effector memory T; 
    MAIT: mucosal-associated invariant T; 
    NKT: natural killer T; 
    Treg: regulatory T cells; 
    HPV: human papillomavirus; 
    TEMRA: T effector memory RA expressing; 
    EBV: Epstein-Barr virus; 
    TNF: tumor necrosis factor; 
    HHV8: human herpesvirus 8; 
    NF-kB: nuclear factor kappa B; 
    NIK: NF-kB-inducing kinase; 
    TREC: T cell receptor excision circle; 
    HCT: hematopoietic cell transplantation; 
    CMV: cytomegalovirus; 
    SLE: systemic lupus erythematosus; 
    ITP: immune thrombocytopenia; 
    AIHA: autoimmune hemolytic anemia; 
    HLH: hemophagocytic lymphohistiocytosis; 
    IKK: IkB kinase.</div><div class="graphic_reference">From: Tangye SG, Al-Herz W, Bousfiha A, et al. Human inborn errors of immunity: 2022 update on the classification from the International Union of Immunological Societies Expert Committee. J Clin Immunol 2022; 42:1473. Copyright © 2022 The Authors. Reproduced under the terms of the <a href="https://creativecommons.org/licenses/by/4.0/" target="_blank">Creative Commons Attribution License 4.0</a>.</div><div id="graphicVersion">Graphic 139920 Version 1.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
